Borviz 3.5 Injection

$186.95

1 Vial, 1 Injection per vial

Active ingredient: Bortezomib (3.5mg)

959 in stock

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Borviz 3.5 Injection
$186.95

Introduction

Borviz is a prescription medication that contains the active ingredient Bortezomib. It is available in the form of an injection and is used for the treatment of certain types of cancer.

Uses

Borviz is primarily prescribed for the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It is also used in the treatment of mantle cell lymphoma, another type of cancer that affects the lymph nodes.

Dosage and Administration

The dosage of Borviz may vary depending on the specific condition being treated and the individual patient. It is typically administered by a healthcare professional in a hospital or clinic setting. The injection is given into a vein (intravenous) and the frequency of administration will be determined by your doctor.

Mechanism of Action

Bortezomib, the active ingredient in Borviz, works by inhibiting the activity of proteasomes, which are enzymes responsible for breaking down proteins in the cells. By blocking the proteasomes, Bortezomib helps to prevent the growth and spread of cancer cells.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, constipation, fatigue, and a decrease in blood cell counts. Report any side effects to your doctor, as they can provide guidance on how to manage them.

Serious side effects of Borviz may include peripheral neuropathy (numbness or tingling in the hands or feet), low platelet count, and low white blood cell count. If you experience any of these serious side effects, seek medical attention immediately.

Drug Interactions

Borviz may interact with other medications, including certain antibiotics, antifungals, and antiviral drugs. Inform your doctor about all the medications you are currently taking, including prescription, over-the-counter, and herbal supplements, to avoid any potential drug interactions.

Precautions

Before using Borviz, inform your doctor about any medical conditions you have, especially if you have liver or kidney problems. This medication should not be used during pregnancy or while breastfeeding, as it may harm the unborn baby or pass into breast milk.

Borviz may also interact with certain substances, such as alcohol. Avoid consuming alcohol while receiving this medication, as it may increase the risk of side effects.

Storage

Borviz should be stored at room temperature, away from direct light and moisture. Keep the medication out of the reach of children and pets. Do not use the medication if the packaging is damaged or if the expiration date has passed.

Patient Tips

  • Follow your doctor’s instructions on how to take Borviz and adhere to the prescribed dosage schedule.
  • Keep all scheduled appointments with your healthcare provider for regular check-ups and monitoring.
  • Report any side effects or concerns to your doctor promptly.
  • Take steps to prevent infection, as Borviz may lower your body’s ability to fight off infections.
  • If you miss a dose, contact your healthcare provider for guidance on what to do next.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

  • Bortezomib 1mg powder for solution for injection (Health Professionals SmPC) Available at:
  • Bortezomib (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
  • bortezomib 3.5 mg injection powder for solution antineoplastic – proteasome enzyme inhibitors (RX) [Accessed 12 Jun. 2024] (online) Available at:
  • Bortezomib (MedlinePlus) [Accessed 14 Jun. 2024] (online) Available at:
  • Yamamoto S, Egashira N. Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy. Int J Mol Sci. 2021 Jan 17;22(2):888. doi: 10.3390/ijms22020888. [Accessed 26 Jun. 2024] Available at:

Additional information

Active ingredients

Strength

Bortezomib (3.5mg)

Indications

Multiple myeloma, Mantle-cell lymphoma

Brand

Manufacturer

Manufacturer's location

Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.

Reviews

There are no reviews yet.

Be the first to review “Borviz 3.5 Injection”

Your email address will not be published. Required fields are marked *